Substance P and thiorphan synergically enhance angiogenesis in wound healing

[1]  Ki-Sook Park,et al.  Substance P enhances the proliferation and migration potential of murine bone marrow-derived mesenchymal stem cell-like cell lines , 2015, Experimental and therapeutic medicine.

[2]  T. R. Lee,et al.  Substance P stimulates endothelin 1 secretion via endothelin-converting enzyme 1 and promotes melanogenesis in human melanocytes. , 2015, The Journal of investigative dermatology.

[3]  Lixin Xie,et al.  Substance P Promotes Diabetic Corneal Epithelial Wound Healing Through Molecular Mechanisms Mediated via the Neurokinin-1 Receptor , 2014, Diabetes.

[4]  Amit Kumar,et al.  Topically applied substance P enhanced healing of open excision wound in rats. , 2013, European journal of pharmacology.

[5]  Jeong Bae Park,et al.  The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development , 2013, Korean journal of pathology.

[6]  D. Nanus,et al.  Negative regulation of NEP expression by hypoxia , 2013, The Prostate.

[7]  H. Northoff,et al.  Mesenchymal stromal/stem cells markers in the human bone marrow. , 2013, Cytotherapy.

[8]  S. Moochhala,et al.  The Role of Neutral Endopeptidase in Caerulein-Induced Acute Pancreatitis , 2011, The Journal of Immunology.

[9]  H. Hong,et al.  A new role of substance P as an injury-inducible messenger for mobilization of CD29+ stromal-like cells , 2009, Nature Medicine.

[10]  L. Hersh,et al.  Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis , 2008, Prostate Cancer and Prostatic Diseases.

[11]  K. Davies,et al.  Sialorphin (the mature peptide product of Vcsa1) relaxes corporal smooth muscle tissue and increases erectile function in the ageing rat , 2007, BJU international.

[12]  P. Gressens,et al.  Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice. , 2006, Brain : a journal of neurology.

[13]  D. Nanus,et al.  Neprilysin Inhibits Angiogenesis via Proteolysis of Fibroblast Growth Factor-2* , 2006, Journal of Biological Chemistry.

[14]  R. Butt,et al.  Increased skin collagen extractability and proportions of collagen type III are not normalized after 6 months healing of human excisional wounds. , 2003, The Journal of investigative dermatology.

[15]  S. Werner,et al.  Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.

[16]  J. Olerud,et al.  Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. , 2002, The Journal of investigative dermatology.

[17]  Xiaodong Feng,et al.  Angiogenesis in wound healing. , 2000, The journal of investigative dermatology. Symposium proceedings.

[18]  J. Olerud,et al.  Neutral endopeptidase expression and distribution in human skin and wounds. , 1999, The Journal of investigative dermatology.

[19]  C. Franceschi,et al.  Neutral endopeptidase-24.11 (NEP) activity in human fibroblasts during development and ageing , 1998, Mechanisms of Ageing and Development.

[20]  M. Fournié-Zaluski,et al.  Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. , 1993, Pharmacological reviews.

[21]  S. Wientroub,et al.  Neutral endopeptidase (EC 3.4.24.11) is highly expressed on osteoblastic cells and other marrow stromal cell types. , 1990, Biochemical and biophysical research communications.

[22]  A. Turner,et al.  The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11. , 1984, The Biochemical journal.

[23]  G. Crooks,et al.  Lymphoid priming in human bone marrow begins before expression of CD 10 with upregulation of L-selectin , 2012 .